- Investing Ideas
- /
- Swiss Undervalued Stocks Based On Cash Flows
Swiss Undervalued Stocks Based On Cash Flows
UPDATED May 31, 2024
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
13 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
BAER | CHF54.08 | -3.2% | -5.5% | CHF11.1b | CHF61.56 | PE24.4x | E21.9% | 4.8% | Diversified Financials | ||
COTN | CHF333.50 | -2.9% | 35.2% | CHF2.6b | CHF367.80 | PE168.4x | E41.4% | 0.3% | Tech | ||
MED | CHF76.50 | 0.1% | -0.1% | CHF1.0b | CHF98.98 | PE1678.1x | E60.4% | n/a | Healthcare | ||
SOON | CHF284.80 | -3.2% | 19.1% | CHF17.0b | CHF279.12 | PE28.2x | E10.3% | 1.5% | Healthcare | ||
CLTN | CHF50.80 | -3.1% | -28.8% | CHF303.6m | CHF62.00 | PE25.4x | E20.9% | 3.9% | Healthcare | ||
SGSN | CHF84.00 | -1.1% | 0.1% | CHF15.9b | CHF88.23 | PE28.8x | E9.8% | 3.8% | Commercial Services | ||
TEMN | CHF58.00 | 1.2% | -25.8% | CHF4.2b | CHF69.50 | PE34.2x | E14.7% | 2.0% | Software | ||
LONN | CHF486.40 | -5.6% | -17.1% | CHF35.1b | CHF576.86 | PE53.6x | E20.7% | 0.8% | Pharmaceuticals & Biotech | ||
SQN | CHF275.40 | -0.6% | 51.2% | CHF4.1b | CHF247.00 | PE18.8x | E14.3% | 1.6% | Diversified Financials | ||
MOVE | CHF122.80 | 0.3% | 6.0% | CHF2.4b | CHF142.95 | PE52.8x | E21.8% | 0.4% | Healthcare | ||
KUD | CHF1.44 | -3.7% | -22.6% | CHF80.7m | CHF1.26 | PB0.3x | E106.5% | 0% | Tech | ||
AERO | CHF19.60 | 0.9% | 40.0% | CHF1.2b | CHF23.18 | PB1.3x | E54.8% | n/a | Capital Goods | ||
SIKA | CHF272.90 | -3.8% | 6.7% | CHF43.8b | CHF294.48 | PE41.2x | E12.5% | 1.2% | Materials |
Page 1 of 1